A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2004
11/11/2004	US20040224921 Fluorescent cobalamins and uses thereof
11/11/2004	US20040224905 Applying to an area in need thereof, an effective amount of a one or more rhamnolipids for therapy of gingivitis
11/11/2004	US20040224903 Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device
11/11/2004	US20040224902 Process for obtaining lignans
11/11/2004	US20040224890 Nasal calcitonin formulations containing chlorobutanol
11/11/2004	US20040224886 Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins
11/11/2004	US20040224864 sterilization of embolic compositions comprising hydroxyl-containing rheological modifier(s) using irradiation techniques provides sterilized compositions exhibiting minimal changes in its thioxotropic behavior; prolonged shelf life with limited changes in viscosity
11/11/2004	US20040224366 Valency platform molecules comprising aminooxy groups
11/11/2004	US20040224355 Using guanylate cyclase gene expression for imaging and treating primary and/or metastatic stomach or esophageal cancer; tissue targeted therapy; genetic vaccines; immunotherapy
11/11/2004	US20040224347 Methods for identification, diagnosis, and treatment of breast cancer
11/11/2004	US20040224335 Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
11/11/2004	US20040224077 Reacting Arg-Phe together with a reducing sugar to a Maillard reaction under condition sufficient to form the flavor active compound; useful for cosmetics, food and drugs
11/11/2004	US20040224036 Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals
11/11/2004	US20040224027 useful for tissue regeneration, particularly when used with orthopedic implants and drug delivery
11/11/2004	US20040224026 Collagen/polysaccharide bilayer matrix
11/11/2004	US20040224025 Fish gelatin compositions containing a hydrocolloid setting system
11/11/2004	US20040224024 water-insoluble complex formed of a charged drug and a polyion such as polyelectrolyte dextran sulfate and a therapeutic protein
11/11/2004	US20040224023 Compositions and methods for treating or preventing diseases of body passageways
11/11/2004	US20040224022 Collagen/polysaccharide bilayer matrix
11/11/2004	US20040224016 particles of biologically active, non-aggregated erythropoietin in contact with a salting-out salt dispersed within a biodegradable polymeric matrix; smaller amounts of EPO are used compared to bolus injection regimen because serum EPO levels are maintained closer to therapeutical thresholds.
11/11/2004	US20040224014 particularly norfloxacin, containing an inorganic or organic acid stabilizer; for preparing a tablet by wet granulation
11/11/2004	US20040224013 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
11/11/2004	US20040224009 Devices comprising artificial antigen-presenting cellls
11/11/2004	US20040223997 Antifungal parenteral products
11/11/2004	US20040223984 Topical testosterone formulations and associated methods
11/11/2004	US20040223961 Enzyme treatment
11/11/2004	US20040223950 the bond to the IFN-alpha 2a is at a lysine residue; isolation using liquid chromatography; prophylaxis of viral or immunomodulatory diseases, especially for the treatment of viral diseases
11/11/2004	US20040223948 Drug-oligomer conjugates with polyethylene glycol components
11/11/2004	US20040223944 Antimicrobial silver ion complex resinates
11/11/2004	US20040223911 Stabilized therapeutic and imaging agents
11/11/2004	CA2847543A1 Annatto extract compositions, including geranyl geraniols and methods of use
11/11/2004	CA2826735A1 Methods for treating cancer using an immunotoxin
11/11/2004	CA2524124A1 Methods for treating cancer using an immunotoxin
11/11/2004	CA2523600A1 Methods utilising g-protein coupled receptor 54
11/11/2004	CA2523341A1 Compositions and methods for treatment of psoriasis
11/11/2004	CA2523266A1 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof
11/11/2004	CA2523083A1 Antiviral phosphonate analogs
11/11/2004	CA2522890A1 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through anti-sense and sense peptide nucleic acids
11/11/2004	CA2522845A1 Kinase inhibitor phosphonate conjugates
11/11/2004	CA2521735A1 Fast dissolving orally consumable films containing a sucralose as a sweetener
11/11/2004	CA2521560A1 Hsa-free stabilized interferon liquid formulations
11/11/2004	CA2521162A1 Single chain antigen-binding polypeptides for polymer conjugation
11/11/2004	CA2511353A1 Solid dosage form comprising desmopressin and method for manufacturing thereof
11/10/2004	EP1475440A2 Growth differentiation factor-3
11/10/2004	EP1475363A1 Method for stabilizing reduced coenzyme q 10 and composition therefor
11/10/2004	EP1475114A2 Injection system suitable for the administration of semisolid, sustained-release pharmaceutical compositions of gelable peptide salts
11/10/2004	EP1475104A1 Stabilized proteinic preparation
11/10/2004	EP1475101A1 Antibody-containing solution pharmaceuticals
11/10/2004	EP1475100A1 Antibody-containing solution pharmaceuticals
11/10/2004	EP1475098A1 High-concentration preparation of soluble thrombomodulin
11/10/2004	EP1475095A1 Percutaneous preparations
11/10/2004	EP1475091A1 Mycophenolate mofetil - high dose oral suspensions
11/10/2004	EP1475089A1 Process for producing granules containing branched amino acids
11/10/2004	EP1475085A1 Controlled-release formulations coated with aqueous dispersions of ethylcellulose
11/10/2004	EP1475084A1 Tablets having improved tabletting characteristics and process for producing the same
11/10/2004	EP1475083A1 Method for producing an active ingredient concentrate, and active ingredient concentrate
11/10/2004	EP1475070A1 Water-in-oil emulsion composition and emulsion cosmetic comprising the same
11/10/2004	EP1474521A2 An herpes simplex virus complex
11/10/2004	EP1474510A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
11/10/2004	EP1474438A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
11/10/2004	EP1474433A2 RNA INTERFERENCE MEDIATED TARGET DISCOVERY AND TARGET VALIDATION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/10/2004	EP1474376A1 Carboxylic acid compounds for use as surfactants
11/10/2004	EP1474196A1 Methods and systems for operating an aerosol generator
11/10/2004	EP1474182A1 Composition for skin healing comprising a chitosan hydrogel
11/10/2004	EP1474174A1 Composition for oral or rectal administration
11/10/2004	EP1474173A2 Composition and method for protecting labile active components
11/10/2004	EP1474172A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
11/10/2004	EP1474171A1 Weight management system for obese animals
11/10/2004	EP1474162A1 Methods and compositions for the treatment of eye diseases
11/10/2004	EP1474159A2 Compositions containing oat straw and willowherb extract
11/10/2004	EP1474154A2 Improvements in or relating to compositions
11/10/2004	EP1474153A2 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
11/10/2004	EP1474152A1 Orodispersible pharmaceutical composition comprising ivabradine
11/10/2004	EP1474144A1 Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
11/10/2004	EP1474120A2 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
11/10/2004	EP1474118A1 Composition for inhalation
11/10/2004	EP1474117A1 Composition for inhalation
11/10/2004	EP1474116A1 Colonic release composition
11/10/2004	EP1474115A1 Non-gelatin capsule shell formulation comprising iota-carrageenan and kappa-carrageenan
11/10/2004	EP1474114A1 Oral dosage form for controlled drug release
11/10/2004	EP1474113A1 Edible pga coating composition
11/10/2004	EP1474110A1 Depot medicament, carrier materials for depot medicaments, and method for the production thereof
11/10/2004	EP1474109A2 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
11/10/2004	EP1474108A2 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
11/10/2004	EP1474103A1 Levothyroxine compositions and methods
11/10/2004	EP1474101A1 Anti-microbial composition comprising a metal ion chelating agent
11/10/2004	EP1474085A2 In situ bonds
11/10/2004	EP1200521B1 Dispersion comprising a non-ionic emulsifier
11/10/2004	EP1131050B8 Galenic formulations fast disintegrating in the mouth and method for preparing same
11/10/2004	EP1107750B1 Pharmaceutical composition with antitumor activity on the basis of carboplatin
11/10/2004	EP1061901B1 Nicotine inhaler
11/10/2004	EP1045700B1 Oral delivery of nucleic acid vaccines by particulate complexes
11/10/2004	EP0975348B1 Stabilized tibolone compositions
11/10/2004	CN1545522A Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods expecially for use as a plasma volume expander
11/10/2004	CN1545425A Light-stabilized in vivo stain composition and method of manufacture
11/10/2004	CN1545424A Anti-cancer medicine comprising disintegrin genes and treating methods thereof
11/10/2004	CN1545423A Pharmaceutical compositions comprising polysaccharide conjugates for inhibiting the metastsis or preventing the recurrence of maligant tumor
11/10/2004	CN1545422A Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingred
11/10/2004	CN1545421A Pharmaceutical compositions of drugs and neutralized acidic polymers
11/10/2004	CN1545420A Topical composition, topical composition precursor, and methods for manufacturing and using

1 ... 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 ... 1712